Janux Therapeutics, Inc.
JANX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24 | -$34 | -$24 | -$20 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9 | $11 | $11 | $6 |
| Change in WC | $7 | $4 | -$1 | -$0 |
| Other Non-Cash | -$5 | -$5 | -$4 | -$3 |
| Operating Cash Flow | -$13 | -$24 | -$17 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$118 | -$93 | -$371 | -$24 |
| Inv. Sales/Matur. | $126 | $95 | $31 | $58 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $8 | $2 | -$340 | $34 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1 | $1 | $378 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $8 |
| Financing Cash Flow | $0 | $1 | $1 | $387 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4 | -$21 | -$357 | $404 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53 | $75 | $431 | $28 |
| End Cash | $49 | $53 | $74 | $431 |
| Free Cash Flow | -$13 | -$24 | -$17 | -$17 |